ElementAI: Leveraging AI Solutions for Complex Problems
"Explore how ElementAI addresses the fear of AI while promoting its opportunities, financial analysis, and strategic recommendations. Join this promising startup's journey from inception to growth and learn about its core competencies and value propositions."
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
ELEMENTAI ELEMENTAI AN ELEMENTAL SOLUTION TO AN ELEMENTAL SOLUTION TO A COMPLEX PROBLEM A COMPLEX PROBLEM PRESENTATION TO THE BOARD OF DIRECTORS ORT CONSULTING GROUP ISMAEL ALMANDOS LUCIA BACIGALUPI JOANNA PELUFO CLAUDIA RODRIGUEZ
SITUATION WHERE YOU ARE NOW WHERE YOU WANT TO BE PROMISING STARTUP WITH VERY FAST GROWTH RAISED 250M IN 3 YEARS FIGHTING THE NEGATIVE IMAGE THAT AI HAS CONTINUE GROWING AND INCREASING ADOPTION BE PART OF THE WAVE OF PROGRESS IN AI FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
KEY QUESTION HOW CAN ELEMENTAI FIGHT THE FEAR OF AI WHILE PROMOTING THE OPPORTUNITIES IT PROVIDES AND INCREASE ADOPTION? FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
CORE COMPETENCIES FULL STACK (HAVING FULL CONTROL OF DEVELOPMENT PROCESS) CREATING COSTUMIZED PRODUCTS INDUSTRY KNOW HOW FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
INTEREST GROUPS TARGET AUDIENCE NATURAL PARTNERS LARGE INDUSTRIAL COMPANIES OPEN SOURCE COMPANIES SOLUTIONS PROVIDERS FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
VALUE PROPOSITION HELP COMPANIES OPERATIONALIZE AI TO HELP PEOPLE AND MACHINES WORK TOGETHER FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
NEW VALUE PROPOSITION REDUCE THE COSTS AND THE TIME IN YOUR IMAGE DIAGNOSTICS PROCESS FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
CHALLENGES FIGHT AGAINST LARGE COMPETITORS OVERCOMING FEAR OF AI REDUCE SALES CYCLE INCREASE ADOPTION OF AI AMAZON, GOOGLE AND IBM FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
ALTERNATIVES FOCUS ON DIAGNOSIS BY IMAGES IN THE HEALT INDUSTRY TAKE CONTROL OF YOUR AI FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
ALTERNATIVES CONTINUE OFFERING OUR COSTUMIZED PRODUCTS AND SERVICES HELP DIAGNOSE BREAST, LUNG AND SKIN CANCER THROUGH IMAGE DIAGNOSTICS MANAGE SENTITIVE MEDICAL DATA ON PREMISE RATHER THAN ON THE CLOUD CONTINUE OFFERING A COSTUMIZED SERVICE WORK WITH MEDICAL INSTITUTIONS FOCUS ON DIAGNOSIS BY IMAGES IN THE HEALTH INDUSTRY FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
ALTERNATIVES CONTINUE OFFERING OUR COSTUMIZED PRODUCTS AND SERVICES CONTINUE ADDING VALUE TO COSTUMIZED PRODUCTS TO FIGHT AGAINST YOU COMPETITION SHOW COSTUMERS THAT THEY CONTROL AI NOT THE OTHER WAY ROUND REACH INGENIEERS SINCE THEY DON T FEAR AI AS MUCH SHOW COMPANIES THAT AI IS AN INVISIBLE SOLUTIONS FOR COSTUMERS TAKE CONTROL OF YOUR AI FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
ALTERNATIVES FOCUS ON DIAGNOSIS BY IMAGES IN THE HEALT INDUSTRY TAKE CONTROL OF YOUR AI FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
ALTERNATIVES FOCUS ON DIAGNOSIS BY IMAGES IN THE HEALT INDUSTRY TAKE CONTROL OF YOUR AI PROBLEM SOLUTION FIT FEASIBILITY MID-TERM PROFITABILITY SCALABILITY RISK OF IMPLEMENTATION FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
ALTERNATIVES FOCUS ON DIAGNOSIS BY IMAGES IN THE HEALT INDUSTRY TAKE CONTROL OF YOUR AI PROBLEM SOLUTION FIT FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
ALTERNATIVES FOCUS ON DIAGNOSIS BY IMAGES IN THE HEALT INDUSTRY TAKE CONTROL OF YOUR AI PROBLEM SOLUTION FIT FEASIBILITY FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
ALTERNATIVES FOCUS ON DIAGNOSIS BY IMAGES IN THE HEALT INDUSTRY TAKE CONTROL OF YOUR AI PROBLEM SOLUTION FIT FEASIBILITY MID-TERM PROFITABILITY FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
ALTERNATIVES FOCUS ON DIAGNOSIS BY IMAGES IN THE HEALT INDUSTRY TAKE CONTROL OF YOUR AI PROBLEM SOLUTION FIT FEASIBILITY MID-TERM PROFITABILITY SCALABILITY FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
ALTERNATIVES FOCUS ON DIAGNOSIS BY IMAGES IN THE HEALT INDUSTRY TAKE CONTROL OF YOUR AI PROBLEM SOLUTION FIT FEASIBILITY MID-TERM PROFITABILITY SCALABILITY RISK OF IMPLEMENTATION FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
ALTERNATIVES FOCUS ON DIAGNOSIS BY IMAGES IN THE HEALT INDUSTRY TAKE CONTROL OF YOUR AI PROBLEM SOLUTION FIT FEASIBILITY MID-TERM PROFITABILITY SCALABILITY RISK OF IMPLEMENTATION FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
RECOMMENDATION FOCUS ON DIAGNOSIS BY IMAGES IN THE HEALTH INDUSTRY FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
WHY WE CHOSE THIS OPTION FIGHT AGAINST LARGE COMPETITORS REDUCE SALES CYCLE INCREASE ADOPTION OF AI SHOW POSITIVE IMPACT OF AI ON HEALTH CREATE A UNIQUE PRODUCT OFFERING PAQUETIZED PRODUCT FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
IMPLEMENTATION IMPLEMENTATION FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
IMPLEMENTATION MAINTAIN CURRENT OPERATIONS IN CA, UK, SI, KO WITH ACTUAL BUSINESS MODEL FOCUS SOLELY IN CANADA & US FOR IMAGE DIAGNOSTICS FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
IMPLEMENTATION OPERATIONS MARKETING FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
IMPLEMENTATION PHASE 1 BREAST CANCER PHASE 2 LUNG CANCER OPERATIONS PHASE 2 SKIN CANCER FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
IMPLEMENTATION PARTNERSHIP WITH SIEMENS HEALTHINEERS NEW MEDICAL DIVISION NEW DIGITAL TREATMENT OF IMAGES SPECIALISTS. NEW SALES TEAM FOCUSED ON HEALTH LOBBYISTS OPERATIONS FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
IMPLEMENTATION FOCUS ON BENEFITS ON HEALTH FOR PATIENTS TV ADDS (AWARENESS CAMPAIGNS) HIGH SCHOOL INTERVENTIONS PUBLICITY ON SOCIAL MEDIA TO HUMANIZE FOCUS ON SAVINGS FOR MEDICAL INSTITUTIONS MEDICAL FAIRS MEDICAL CONGRESS PROMOTE MEDICAL ARTICLES PAPERS UNIVERSITIES ALLIANCES CONTINUOUS EDUCATION MARKETING FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
ASSUMPTIONS 6% Interest rate Taxes 25% NWC 10% FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
PROJECT HIGHLIGHTS USD 70 MILL REQUIRED IN 5 YEARS USD 60 MILL NEW FUNDING ROUND USD 10 MILL LOAN FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
MAIN COST DRIVERS CASH FLOW IS AVAILABLE IN ANNEX FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
MAIN SOURCES OF INCOME CASH FLOW IS AVAILABLE IN ANNEX FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
RISKS AND MITIGATIONS RISKS MITIGATION GOOGLE LIKE COMPETITION ON PREM APPROACH LOBBY & AWARENESS REGULATIONS SIEMENS REJECTION APROACH GE FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
CONCLUSION WHERE YOU ARE NOW WHERE YOU WANT TO BE PROMISING STARTUP WITH VERY FAST GROWTH RAISED 250M IN 3 YEARS FIGHTING THE NEGATIVE IMAGE THAT AI HAS CONTINUE GROWING AND INCREASING ADOPTION BE PART OF THE WAVE OF PROGRESS IN AI FOCUS ON DIAGNOSIS BY IMAGES IN THE HEALTH INDUSTRY FINANCIALS RISKS ANALYSIS ALTERNATIVES IMPLEMENTATION RECOMMENDATION
THANKS THANKS ORT CONSULTING GROUP ISMAEL ALMANDOS LUCIA BACIGALUPI JOANNA PELUFO CLAUDIA RODRIGUEZ
ANNEX 0 1 2 3 4 5 6 7 8 9 10 Inc in sales Inc in costs Inc in interests Inc in taxable income Inc in taxes Inc in NWC $ (14,500.00) $ (600.00) $ (15,100.00) $ 3,775.00 $ $ - $ (15,920.00) $ (600.00) $ (16,520.00) $ 4,130.00 $ $ - $ (23,602.60) $ (600.00) $ (24,202.60) $ 6,050.65 $ $ - $ (24,160.68) $ (600.00) $ (24,260.68) $ 6,065.17 $ (50.00) $ 500.00 2,500.00 $ (24,735.50) $ (600.00) $ (22,835.50) $ 5,708.87 $ (250.00) $ 7,000.00 $ (25,327.56) $ (600.00) $ (18,927.56) $ 4,731.89 $ - 10,000.00 $ (25,937.39) $ (600.00) $ (16,537.39) $ 4,134.35 $ (1,000.00) $ 15,000.00 $ (26,565.51) $ (600.00) $ (12,165.51) $ 3,041.38 $ (1,500.00) $ 20,000.00 $ (27,212.48) $ (600.00) $ (7,812.48) $ 1,953.12 $ - 30,000.00 $ (27,878.85) $ (600.00) $ 1,521.15 $ (380.29) $ (3,000.00) $ 45,000.00 $ (28,565.22) $ (600.00) $ 15,834.78 $ (3,958.70) $ - - - 5,800.00 $ 17,676.09 $ Inc in net income (11,325.00) $ (12,390.00) $ (18,151.95) $ (18,245.51) $ (17,376.62) $ (14,195.67) $ (13,403.04) $ (10,624.13) $ (5,859.36) $ (1,859.14) $
ANNEX interest rate Inflation No of salesman Costs of sales Number of researches Costs of reaserches Number of lobbyst Costs of lobbyst Loan 6% 3% 25 $ (150.00) 50 $ (250.00) 5 $ $ 300.00 10,000.00 cost of sales cost of reaserch cost of lobbysts Tax NWC 25% 10%
